title: Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs.
authors.affiliation: Medical Oncology Service, National Cancer Institute, Bethesda, Maryland.
authors.forename: Sham
authors.initials: S
authors.lastname: Mailankody
authors.affiliation: Medical Oncology Service, National Cancer Institute, Bethesda, Maryland.
authors.forename: Vinay
authors.initials: V
authors.lastname: Prasad
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D018795:Device Approval; D004059:Diffusion of Innovation; D016527:Drug Costs; D006801:Humans; D007250:Inflation, Economic; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents